Hypothesis

The aging brain does not lose plasticity; it becomes over‑confident in its predictive models, leading to rigid cognition. If senescent astrocytes and microglia drive this rigidity by secreting a pro‑inflammatory SASP that stabilizes perineuronal nets and dampens synaptic turnover, then a compound that reaches the CNS and selectively clears these cells should re‑introduce controlled uncertainty and improve cognitive flexibility. Quercetin phytosome achieves plasma concentrations that approach in‑vitro senolytic ranges, and its lecithin complex increases lipophilicity, predicting superior blood‑brain barrier (BBB) transit compared with hydrophilic isoquercetin. We therefore hypothesize that oral quercetin phytosome will (1) raise cerebrospinal fluid (quercetin) to ≥1 µM, (2) reduce biomarkers of CNS senescence, and (3) enhance behavioral measures of surprise tolerance and reversal learning in older adults.

Mechanistic Rationale

• BBB permeability: Phytosome formulation raises quercetin’s logP, facilitating passive diffusion across the BBB, whereas isoquercetin’s glucose moiety retains high polarity and limits CNS entry (1).
• Senolytic action in glia: At 1‑10 µM, quercetin inhibits SCF‑β‑TrCP and blocks NF‑κB‑driven SASP IL‑1β, IL‑6, and CXCL8 in microglia and astrocytes, promoting a shift toward a phagocytic, anti‑inflammatory state.
• Extracellular matrix remodeling: Quercetin upregulates MMP‑9 and downregulates tissue inhibitors of metalloproteinases (TIMP‑1), loosening perineuronal nets

Hypothesis

Age‑dependent decline in glutamine import reduces intracellular α‑KG, selectively inhibiting KDM6 demethylases and causing H3K27me3 accumulation at bivalent promoters of tumor‑suppressor genes. Cancer cells overcome this block by upregulating SLC1A5‑mediated glutamine uptake and overexpressing KDM5A, which removes H3K4me3 marks and shifts the same loci toward an active chromatin state, thereby locking in oncogenic transcription.

Mechanistic Basis

• In aging tissues, reduced SLC1A5 expression lowers glutamine flux, limiting α‑KG availability for the Fe²⁺/α‑KG‑dependent KDM6 family (KDM6A/B)【1】. This creates a biochemical bias where KDM6 activity falls faster than KDM5 activity, tipping the H3K4me3/H3K27me3 balance at bivalent domains toward repression.
• Cancer cells frequently exhibit glutamine addiction and heightened SLC1A5 expression, sustaining α‑KG levels that preserve KDM6 function. Simultaneously, oncogenic signaling (e.g., PI3K/AKT) drives KDM5A overexpression【2】, increasing H3K4me3 demethylation and facilitating R‑loop‑mediated viral mimicry when inhibited【4】.
• The opposing enzymatic trajectories at identical genomic loci could explain why aged tissues show a senescence‑associated H3K27me3‑rich landscape, whereas tumors display H3K4me3‑enriched promoters at the same genes, a dichotomy not yet captured by existing cancer‑or‑aging studies.

Testable Predictions

1. Metabolite‑enzyme correlation: In matched young, aged, and tumor samples from the same tissue type, α‑KG concentration will inversely correlate with H3K27me3 levels at bivalent pro

Hypothesis

Core idea: Lamin A/C functions as a phosphorylation‑regulated switch that governs the detachment of lamina‑associated domains (LADs) from the nuclear envelope during DNA damage response and replication stress. In physiological aging, declining CDK1/cyclin B activity leads to hypophosphorylated lamin A/C that remains tightly bound to LADs, impairing the ATM‑LINC‑mediated detachment pathway and causing persistent fork stalling and genomic instability.

Mechanistic rationale

• During mitosis, CDK1/cyclin B phosphorylates lamin A/C on serine 22 and serine 392 (sites previously shown to reduce lamin‑chromatin affinity) [1]. This phosphorylation weakens lamin A/C interactions with LAD‑binding proteins such as LBR and emerin, facilitating the rapid LINC‑driven mobilization of damaged LADs observed after ATM activation [3].
• In aged cells, oxidative stress and reduced cyclin B expression lower CDK1 activity, resulting in hypophosphorylated lamin A/C that exhibits increased residence time at LADs. Consequently, ATM signaling still occurs, but the downstream LINC complex fails to generate sufficient force to detach LADs, prolonging tethering and exacerbating replication stress via PCNA sequestration [2].
• Persistent LAD tethering prevents efficient homologous recombination repair, leading to increased micronuclei formation and cytokinesis failure, as seen when lamin A/C is depleted [4]. Moreover, the stalled forks trigger chronic activation of the ATR‑CHK1 axis, which further suppresses cyclin B synthesis, creating a vicious feedback loop.

Testable predict

Hypothesis

Intermittent, neuron‑specific reduction of METTL3 activity in aged brains will lower excess m6A on synaptic transcripts, shift the balance toward m6A‑dependent decay, and restore proteostatic flux, thereby rescuing cognitive flexibility without globally suppressing methylation.

Mechanistic Rationale

Normal aging shows elevated m6A in 3′UTRs of synaptic genes, which correlates with increased transcription but reduced turnover [1]. METTL3 drives m6A that enhances FOXO3‑mediated translation while simultaneously inhibiting autophagy, whereas loss of METTL14 stabilizes CAMKK2 mRNA to promote autophagic clearance [2]. We propose that hyper‑methylation creates a "methyl‑ trap": transcripts acquire m6A that recruits YTHDF1/3 for translation, but the same modification overloads YTHDF2‑mediated decay pathways, leading to sequestration of YTHDF2 in stress granules and a net block of mRNA turnover. The result is a static proteome where synthesis outpaces degradation, producing proteostatic gridlock that manifests as synaptic rigidity. Intermittent METTL3 inhibition would transiently decrease m6A load, freeing YTHDF2 to resume decay, allowing autophagy (via FOXO3/CAMKK2) to clear excess proteins and reset the transcriptome.

Testable Predictions

1. Aged mice (≥18 mo) treated with a short‑acting, brain‑penetrant METTL3 inhibitor (e.g., STM2457) given 3 days on/4 days off for 4 weeks will show:
   • A 20‑30 % decrease in m6A peaks at synaptic 3′UTRs measured by MeRIP‑seq.
   • Increased YTHDF2 binding to those transcripts (eCLIP) and reduced YTHDF1/3 occupancy.
   • E

Hypothesis

Emodin induces selective apoptosis of senescent cells by simultaneously inhibiting EGFR/MAPK signaling and CDK activity, leading to p53‑dependent p21 up‑regulation, mitochondrial outer‑membrane permeabilization, and a concomitant NF‑κB‑driven SASP reduction.

Mechanistic Rationale

• Emodin blocks EGFR autophosphorylation and downstream MAPK cascade, attenuating survival signals that sustain senescent cell viability (Emodin inhibits M1 macrophage activation via EGFR/MAPK pathway).
• The same compound interferes with AKT/ERK signaling, which indirectly suppresses CDK2/cyclin A and CDK4/cyclin D1 complexes while elevating p21^Cip1/Waf1^ and p53 levels (Emodin downregulates CDK2 and cyclin A/D1).
• In senescent cells, EGFR/MAPK and CDK2 activity are known to phosphorylate and inhibit p53, thereby restraining p21‑mediated cell‑cycle arrest and allowing survival (Emodin sensitizes pancreatic cancer cells to EGFR inhibitors through STAT3 suppression). Dual inhibition therefore releases this brake, amplifying p53 transcriptional activity.
• Elevated p21 promotes cyclin‑dependent kinase inhibition and can shift the balance toward pro‑apoptotic Bcl‑2 family members (e.g., Bax activation, Bcl‑2 down‑regulation), facilitating mitochondrial permeabilization and caspase‑3 activation.
• Parallel NF‑κB inhibition by emodin curtails transcription of SASP components (IL‑6, IL‑1β, TNF‑α), reducing the paracrine pro‑s

Hypothesis The extent of mitochondrial outer membrane permeabilization (miMOMP) acts as a quantitative rheostat that determines the duration and outcome of JNK/AP‑1 signaling. Limited miMOMP releases modest amounts of mitochondrial DNA (mtDNA) into the cytosol, activating the cGAS‑STING pathway just sufficiently to prolong JNK phosphorylation via TBK1‑mediated scaffold stabilization, producing a transient senescent state that can be reversed when mitochondrial stress is alleviated. When miMOMP exceeds a critical threshold, cytosolic mtDNA surpasses the activation threshold for cGAS‑STING, triggering robust TBK1‑IRF3 signaling and concomitant NF‑κB‑driven IL‑1β secretion. IL‑1β then engages its receptor on the same cell (autocrine) and neighboring cells, activating downstream MAPK cascades that sustain JNK/AP‑1 activity independently of the original mitochondrial trigger. This creates a bistable switch: below the threshold, JNK/AP‑1 activity decays upon mitoROS scavenging (e.g., MitoQ) and cells can revert; above the threshold, the IL‑1β‑cGAS‑STING‑JNK loop locks cells into a permanent senescent, SASP‑high state that drives inflammaging.

Key Predictions

1. Graded induction of miMOMP (e.g., using titrated BAX/BAK activators) will produce a linear increase in cytosolic mtDNA measured by qPCR, which correlates with the duration of phospho‑JNK (p‑JNK) signal after wash‑out of the inducer.
2. Pharmacological or genetic inhibition of cGAS or STING will shorten p‑JNK persistence and increase the proportion of cells that regain proliferation after MitoQ treatment, without a

Hypothesis

Aging stem cells lose chromatin accessibility at stemness regulatory elements and gain accessibility at myeloid/ progenitor loci not merely because of passive DNA methylation changes but due to a progressive decline in the activity of the nucleosome‑remodeling CHD4 subunit of the NuRD complex. Reduced CHD4 leads to aberrant nucleosome positioning that occludes binding sites for pro‑quiescence factors (e.g., MEF2C) in hematopoietic and neural stem cells while simultaneously exposing cryptic enhancer regions enriched for CEBP motifs, thereby driving myeloid priming and niche‑adhesion dysregulation. This mechanism predicts that restoring CHD4 activity in aged stem cells will re‑establish youthful accessibility patterns and functional regenerative capacity, whereas CHD4 loss in young cells will recapitulate the aged ATAC‑seq signature.

Testable Predictions

1. Chromatin phenotype – Conditional CHD4 knockout in young HSCs or NSCs will reproduce the aged ATAC‑seq profile: loss of accessibility at stemness enhancers (e.g., GATA2, TAL1) and MEF2C sites, and gain of accessibility at CEBP‑bound myeloid progenitors and niche‑adhesion genes.
2. Rescue experiment – Forced expression of CHD4 (via inducible lentiviral vector) in aged HSCs transplanted into young recipients or in aged hippocampal NSCs will restore accessibility at stemness and quiescence loci, reduce CEBP‑driven myeloid priming, and normalize niche‑adhesion/migration gene accessibility.
3. Functional correlate – CHD4‑rescued aged stem cells will show improved competitive repopulation (HSC) or i

Hypothesis

With age, the inactive X chromosome in females undergoes epigenetic remodeling that reactivates a subset of X-linked genes encoding chromatin modifiers and transcription factors. These reactivated regulators, such as KDM6A (UTX) and DDX3X, enhance hepatic expression of the farnesoid X receptor (FXR) and thereby increase transcription of the ileal bile acid transporter ASBT (SLC10A2). Consequently, older females maintain higher bile acid reabsorption efficiency, preserving a bile acid pool that favors activation of longevity pathways (e.g., TGR5‑cAMP signaling) and limits accumulation of cytotoxic bile acids like deoxycholic acid. In males, who lack a second X chromosome, this regulatory boost is absent, leading to an age‑related decline in ASBT activity, altered bile acid composition, and accelerated senescence. This mechanism explains the female longevity advantage without invoking gonadal hormones.

Testable Predictions

1. X‑linked regulator expression – In liver and intestine of aged female mice, Kdm6a and Ddx3x mRNA and protein levels will be significantly higher than in age‑matched males; silencing Kdm6a in female hepatocytes will reduce Fxr and Asbt mRNA (qPCR, Western blot) and decrease bile acid reabsorption measured by fecal bile acid excretion.
2. Chromatin state – ChIP‑seq for H3K27ac and H3K4me3 at the Fxr and Asbt promoters will show greater enrichment in livers of old females versus old males; this enrichment will be lost after Kdm6a knockdown.
3. Bile acid phenotype – Aged female mice will exhibit a higher proportion of conjugat

Hypothesis

The age‑dependent decline of mitochondrial OGG1 creates a stoichiometric mismatch with APE1, causing accumulation of toxic abasic sites that preferentially activate the cGAS‑STING pathway via mitochondrial DNA release, rather than simple 8-oxoG load.

Rationale

• Mitochondrial OGG1 expression drops ~2‑fold in aged brains 1.
• APE1 activity also declines, but neuron‑specific APE1 loss accelerates cognitive aging and reduces LTP 2.
• When OGG1 excises 8-oxoG, it leaves an abasic site that APE1 must cleave; if APE1 is limiting, abasic intermediates persist 6.
• Persistent abasic sites can destabilize mitochondrial DNA, promoting its escape into the cytosol where it activates cGAS‑STING 1.
• Current single‑target OGG1 overexpression may worsen the bottleneck if APE1 is not concurrently restored.

Predictions

1. In aged neurons, the ratio of OGG1 activity to APE1 activity will correlate inversely with cytosolic mtDNA levels and STING phosphorylation.
2. Restoring APE1 to match OGG1 overexpression will reduce abasic site accumulation, limit mtDNA release, and lower neuroinflammation more effectively than OGG1 overexpression alone.

Chronic low‑grade nociceptive activity maintains a tonic calcium influx through Cav1.2 channels in peripheral sensory neurons. This depolarization‑evoked Ca2+ rise activates PKA, which phosphorylates CREB and drives transcription of genes that bolster cellular repair, immune surveillance and metabolic recalibration. Many of these CREB‑dependent targets overlap with the FOXO‑ and Nrf2‑regulated stress‑response networks that are known to extend lifespan when persistently active in model organisms. Epidemiological data show that older adults routinely use NSAIDs and other analgesics to suppress pain, yet no study has tested whether blunt­ing this physiological calcium signal erodes the very transcriptional programs that preserve stress resistance.

We hypothesize that habitual analgesic exposure reduces Cav1.2‑mediated Ca2+ spikes, lowering PKA‑CREB signaling and consequently diminishing FOXO nuclear translocation and Nrf2‑dependent antioxidant expression. The resulting hypo‑activity of these transcription factors accelerates the genetically‑programmed inactivation of stress‑resistance pathways described in aging literature, leading to earlier onset of epigenetic drift, increased frailty and shortened healthspan. In other words, analgesics may convert a hormetic nociceptive cue into a silent driver of aging.

This hypothesis is testable and falsifiable through complementary human and animal approaches. In a longitudinal cohort of adults aged 60‑80, we would quantify habitual NSAID/acetaminophen use via pharmacy records, assess pain sensitivity with quantitative sensory testing

Hypothesis

Age‑related decline in the extracellular amyloid‑like fibrillization of undercarboxylated osteocalcin (ucOC) reduces its capacity to sequester calcium ions during mineralization, leading to larger hydroxyapatite (HA) crystals, increased brittleness, and higher fracture risk. Restoring ucOC fibrillization will limit HA crystal size and improve bone material properties.

Mechanistic Rationale

1. ucOC as a calcium‑buffering scaffold – ucOC possesses a high affinity for calcium and, under oxidative conditions typical of aging bone matrix, can undergo regulated amyloidogenesis to form extracellular fibrils. These fibrils present a periodic array of acidic residues that bind Ca²⁺ with nanomolar affinity, creating a diffusible calcium‑sequestering phase that slows HA nucleation and growth.
2. Proteostasis shift with age – In young bone, chaperones and extracellular proteases favor the soluble, hormonally active ucOC pool while allowing a minor fraction to fibrillize. Transcriptional “memory” in stromal stem cells (see 3) shifts the balance toward increased total ucOC expression but simultaneously overwhelms extracellular proteostasis, reducing fibrillization efficiency.
3. Consequences for mineral morphology – When ucOC fibrils are scarce, calcium ions remain freely available, promoting uncontrolled HA growth and the formation of large, plate‑like crystals (see 5). Larger crystals increase elast

Hypothesis

Age‑related atrophy of the adrenal zona reticularis lowers circulating DHEA‑S, which diminishes sigma‑1 receptor–driven astrocytic aquaporin‑4 (AQP4) translocation to perivascular endfeet, thereby impairing glymphatic influx during slow‑wave sleep. Restoring physiologic night‑time DHEA‑S levels will reactivate AQP4‑dependent CSF flow, rescue the brain’s nocturnal "autopsy," and interrupt the maladaptive HPA‑axis feedback loop.

Mechanistic Rationale

DHEA functions as an endogenous agonist of the sigma‑1 receptor (1). Sigma‑1 activation in astrocytes triggers ER calcium release, promoting AQP4 phosphorylation and its enrichment at vascular endfeet (2). In aged animals, zona reticularis loss reduces DHEA‑S, decreasing sigma‑1 tone and causing AQP4 mislocalization, a state linked to reduced glymphatic influx (3). The resulting accumulation of metabolic waste and inflammatory mediators amplifies neuroinflammation, which blunts glucocorticoid feedback, flattens corticosterone rhythms, and further suppresses slow‑wave sleep (4,5). This creates a self‑reinforcing cycle that accelerates neuroendocrine aging.

Predictions & Experimental Design

Baseline characterization – Cohorts of young (3‑month) and aged (18‑month) C57BL/6 mice will be monitored for serum DHEA

Hypothesis

Transient hormetic activation creates an epigenetic memory that prioritizes short‑term stress resistance at the expense of long‑term repair, leading to physiological legacies that reduce resilience upon repeated stress.

Rationale

• Hormetic stressors (heat, fasting, radiation) trigger inducible pathways such as HSPs, Nrf2‑mediated antioxidant response, and the unfolded protein response, which are transient and stress‑activated Hormetic stressors increase stress resistance in early-adult C. elegans but late-life treatments yield modest or no longevity gains.
• In C. elegans, early‑life hormesis extends lifespan but late‑life treatments give minimal gain, indicating the response does not reverse damage No compelling evidence that hormesis extends lifespan in humans; benefits viewed as improving stress resistance rather than rejuvenation.
• Corals that survive heatwaves via hormetic acclimation suffer physiological legacies that impair performance during subsequent stress events Coral stress responses to thermal stress and acidification activate HSPs and UPR, enabling acclimation, but show only delayed dysfunction, not extended lifespan.
• These observations suggest hormesis trades long‑term resilience for short‑term survival, a pattern expected if the pathway is a threat‑reactive system rather than a rejuvenation mechanism [Recovery post‑heatwave leaves physiological legacies impairing future perform

Hypothesis

The BAG3‑HSP70‑HSPB8 chaperone‑assisted selective autophagy (CASA) system functions not merely as a stress‑responsive proteostasis module but as an evolutionarily tunable mechanostat that deliberately shifts cellular resources from late‑life tissue maintenance to early‑life reproductive effort. Chronic activation of YAP/TAZ downstream of BAG3 sustains mTORC1 signaling, suppresses autophagic flux, and promotes a senescence‑associated secretory phenotype (SASP) that remodels the extracellular matrix to favor gonadal output and mating success. If this trade‑off is adaptive, experimentally dampening the BAG3‑YAP/TAZ axis after peak reproduction should extend healthspan without reducing lifetime fecundity, whereas persistent activation should accelerate age‑related decline even in short‑lived genotypes.

Mechanistic Rationale

1. Dual role of BAG3 in young organisms – In muscle, BAG3 couples the removal of mechanically damaged filamin to YAP/TAZ‑driven synthesis of new filamin, preserving contractility (see [3][4]). This loop is advantageous when mechanical load is high and reproductive output is prioritized.
2. Age‑dependent shift in BAG3 isoform usage – Oxidative stress in aging upregulates BAG3 over the proteasome‑linked BAG1, yet autophagic flux declines ([5]). The resulting accumulation of ubiquitinated substrates reflects a failure to upgrade CASA capacity, not a passive loss of function.
3. Mechanical feedback via YAP/TAZ – Persistent nuclear YAP/TAZ, driven by stiffened extracellular matrix, maintains mTORC1 activity and inhibits autophagy ([

Hypothesis

Indole-3-propionic acid (IPA) protects telomere integrity by scavenging telomere‑associated reactive oxygen species, thereby preserving telomeric information entropy and delaying senescence independent of telomere length.

Mechanistic Rationale

Telomeres function not as simple division counters but as repositories of genetic information whose fidelity is threatened by oxidative damage. Oxidative lesions at telomeres generate telomere dysfunction‑induced foci (TIFs) that trigger a DNA damage response, leading to senescence even when repeat length remains unchanged [6][7]. IPA, a tryptophan‑derived metabolite produced by gut Clostridium sporogenes, exhibits potent antioxidant activity in aged tissues [3]. Its small, lipophilic structure enables rapid diffusion across nuclear membranes, positioning it to neutralize hydroxyl radicals and peroxynitrite that preferentially attack guanine repeats in telomeric DNA.

We propose that IPA’s primary anti‑aging action lies in safeguarding telomeric sequence information rather than elongating repeats. By lowering oxidative insult, IPA reduces the formation of 8‑oxoguanine lesions within telomeres, decreasing the probability that shelterin complexes dissociate and that ATM/ATR kinases are activated. Consequently, cells experience fewer TIFs, lower p16^INK4a^ expression, and delayed entry into the senescence program.

Predictions

1. In human fibroblasts, exogenous IPA will decrease telomere‑specific oxidative damage markers (e.g., telomeric 8‑oxoguanine) without altering average telomere length measured by qPCR or TRF

Hypothesis

With age, circulating undercarboxylated osteocalcin (ucOC) declines, yet exogenous ucOC fails to fully rescue anabolic signaling in aged muscle despite restoring hormone levels. We propose that aging remodels GPRC6A coupling specificity in skeletal muscle, shifting the receptor from a Gq/IP3‑Ca2+‑driven mTOR anabolic state to a Gs/cAMP‑PKA‑biased state that preferentially activates IL‑6/STAT3‑dependent autophagy. This biased signaling, rather than mere ligand scarcity, underlies the observed dissociation between ucOC availability and muscle mass maintenance.

Mechanistic Rationale

1. Receptor bias via GRK/β‑arrestin remodeling – In young muscle, ucOC-bound GPRC6A preferentially engages Gq proteins, activating PLCβ, IP3‑mediated Ca2+ release, and downstream mTORC1 activation (see 2). Aging is associated with upregulation of G protein‑coupled receptor kinases (GRK2/3) and β‑arrestin2 in many tissues (5). Increased GRK activity phosphorylates the intracellular loops of GPRC6A, promoting β‑arrestin recruitment that sterically hinders Gq coupling while facilitating Gs activation (2). The resulting cAMP surge activates PKA, which phosphorylates CREB and drives IL‑6 transcription, engaging STAT3‑mediated autophagy (4).

2. Osteoclast‑derived exosomal microRNA modulation – Osteoclasts release exosomes enriched in miR‑21 during resorption ([1](ht

Hypothesis: In aging liver, elevated primary bile acids activate the hepatocyte‑expressed receptor TGR5, initiating a cAMP‑PKA cascade that phosphorylates NAMPT and diminishes its catalytic activity, thereby reducing NAD+ salvage synthesis. This suppression is not a passive consequence of damage but an adaptive feedback loop designed to limit PARP‑driven NAD+ consumption that is amplified by bile‑acid‑induced oxidative stress. By lowering NAD+ availability, the cell attenuates hyperactive PARP, conserving ATP and reducing necrotic signaling, even though this comes at the cost of diminished sirtuin activity and impaired DNA repair over time.

Mechanistic

rationale: Primary bile acids such as cholic acid act as agonists for TGR5, raising intracellular cAMP and activating protein kinase A (PKA). PKA can phosphorylate NAMPT at conserved serine residues (e.g., Ser¹⁰⁰ in mouse NAMPT), a modification shown in vitro to decrease its V_max for NMN production (1). Phosphorylated NAMPT exhibits reduced affinity for its substrate NAMPT, leading to lower intracellular NAD+ pools. The resulting NAD+ decline limits the substrate for PARP1/2, which are hyperactivated by bile‑acid‑induced ROS and DNA damage (3). Simultaneously, reduced NAD+ diminishes SIRT1 deacetylase activity, favoring a more glycolytic, stress‑resistant metabolic state that short‑term protects hepatocytes from apoptosis.

Testable predictions: 1) Pharmacological inhibition of TGR5 (e

Hypothesis

In aging neurons, chronic oxidative stress triggers a selective autophagy program that targets base excision repair (BER) enzymes—specifically OGG1 and APE1—for lysosomal degradation. This is not a generic clearance mechanism but a rationing decision: the cell sacrifices DNA repair capacity to mobilize amino acids and sustain essential bioenergetic processes under prolonged siege. Consequently, autophagy activation exacerbates 8‑oxoguanine accumulation and accelerates neurodegeneration.

Mechanistic Rationale

• Oxidative modifications (e.g., carbonylation, sulfonylation) on OGG1 and APE1 create epitopes recognized by the autophagy adaptor p62/SQSTM1.
• p62 binds both ubiquitinated BER proteins and LC3 on nascent autophagosomes, directing them into the lysosome.
• Lysosomal degradation releases glutamate, aspartate, and other metabolites that feed the TCA cycle, supporting ATP production when glycolytic flux is limited by mitochondrial damage.
• This trade‑off mirrors the "siege" analogy: the neuron cannibalizes its genome‑maintenance machinery to keep the lights on.

Testable Predictions

1. Inhibition of lysosomal autophagy preserves BER activity
   • Neurons treated with chloroquine, bafilomycin A1, or with ATG5/ATG7 knock‑down will show higher OGG1/APE1 protein levels and lower 8‑oxoguanine immunostaining after paraquat or H₂O₂ exposure compared with controls.

Hypothesis

mTORC1 activity does not only regulate EZH2 translation and H3K27me3 levels; it also governs the nuclear import of the H3K27me3 demethylase Jmjd3 via phosphorylation of Importin‑7. This creates a biphasic control of CDKN2A/B expression: moderate mTOR inhibition favors Jmjd3 nuclear accumulation and transient p16^INK4a up‑regulation (a protective senescence response), whereas strong or chronic inhibition impairs Importin‑7‑mediated import, reducing nuclear Jmjd3 and paradoxically lowering CDKN2A/B transcription despite low EZH2 activity.

Mechanistic Rationale

1. mTORC1‑dependent phosphorylation of Importin‑7 – mTORC1 substrates include ribosomal protein S6 kinase (S6K) and 4E‑BP1; we propose that Importin‑7 is a direct mTORC1 target. Phosphorylation enhances its affinity for the Jmjd3‑importin complex, promoting nuclear entry.
2. Jmjd3 activity requires nuclear localization – demethylation of H3K27me3 at the CDKN2A/B promoter can only occur when Jmjd3 reaches chromatin. Cytoplasmic retention renders the enzyme inactive regardless of its expression level.
3. Dose‑dependent outcome – At basal or mildly reduced mTORC1 activity (e.g., intermittent fasting), Importin‑7 remains sufficiently phosphorylated, allowing Jmjd3 to enter the nucleus and demethylate the locus, raising p16^INK4a to a level that enforces cell‑cycle arrest without triggering chronic inflammation. At profound mTORC1 suppression (e.g., high‑dose rapamycin, genetic Raptor loss), Importin‑7 phosphorylation drops, Jmjd3 stays cytoplasmic, H3K27me3 persists, and CDKN2A/B transcription